Browse Category

Financial News News 13 December 2025

Arista Networks Stock Forecast: ANET Slumps After a 7‑Day Rally as AI Spending Jitters Return — What to Watch Next Week (Updated Dec. 12, 2025)

Arista Networks Stock Forecast: ANET Slumps After a 7‑Day Rally as AI Spending Jitters Return — What to Watch Next Week (Updated Dec. 12, 2025)

Arista Networks, Inc. (NYSE: ANET) ended Friday, December 12, 2025, at $124.76, sliding 7.17% and snapping a seven-session winning streak just one day after closing at $134.39. MarketWatch+1The selloff arrived as the broader “AI trade” turned volatile again, after disappointing
Analog Devices (ADI) Stock Update: Fresh 52-Week Highs, Insider Filings, Analyst Targets — What to Watch Next Week (Updated Dec. 12, 2025)

Analog Devices (ADI) Stock Update: Fresh 52-Week Highs, Insider Filings, Analyst Targets — What to Watch Next Week (Updated Dec. 12, 2025)

Analog Devices, Inc. (NASDAQ: ADI) ended Friday, December 12, 2025, at $279.32, down 1.44% on the day, after briefly trading in the mid-$280s and notching new highs earlier in the week. MarketWatch+1The bigger takeaway for investors: ADI’s trend remains constructive
Charles Schwab (SCHW) Stock This Week: Client Assets Hit $11.83 Trillion as the Fed Cuts Rates — What Investors Are Watching Next Week (Updated Dec. 12, 2025)

Charles Schwab (SCHW) Stock This Week: Client Assets Hit $11.83 Trillion as the Fed Cuts Rates — What Investors Are Watching Next Week (Updated Dec. 12, 2025)

Updated: December 12, 2025Company: The Charles Schwab Corporation (The)Ticker:NYSE: SCHW Charles Schwab stock closed the week with a modest gain, even after a soft finish on Friday. The backdrop was anything but quiet: Schwab published fresh November client-activity metrics, the
13 December 2025
Pfizer Stock (PFE) Outlook: GLP‑1 Weight‑Loss Deal, Tukysa Trial Win, Dividend Declared — and the Big Catalyst Next Week (Updated Dec. 12, 2025)

Pfizer Stock (PFE) Outlook: GLP‑1 Weight‑Loss Deal, Tukysa Trial Win, Dividend Declared — and the Big Catalyst Next Week (Updated Dec. 12, 2025)

Updated Friday, Dec. 12, 2025. Pfizer (NYSE: PFE) heads into the final full trading week before the holidays with a familiar mix of catalysts: pipeline updates that support its post‑COVID growth narrative, dealmaking in the red‑hot obesity space, and renewed
1 188 189 190 191 192 316
Go toTop